• Bioalliance Pharma SA, of Paris, was issued a South Korean patent for Sitavig (acyclovir mucoadhesive tablet) for treating recurrent labial herpes in adults. The patent is based on the product’s original manufacturing process, which gives Sitavig its adhering property.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST